新達控股(08471.HK)預期一季度虧損230萬元
格隆匯4月28日丨新達控股(08471.HK)發佈公告,公司預期收益將由截至2019年3月31日止3個月約人民幣1950萬元下跌至截至2020年3月31日止3個月約人民幣970萬元。與上年同期虧損約人民幣200萬元相比,預期期間取得虧損約人民幣230萬元。
收益下跌乃主要由於新型冠狀病毒疫情爆發對中國經濟及生產活動,包括集團從事服裝製造的客户的生產活動構成干擾;集團客户因貿易保護主義的出現及中國和美國的貿易糾紛持續而持續採取削減成本的措施;宏觀經濟環境充滿挑戰及中國經濟增長放緩導致服裝市場需求降低;服裝市場價格競爭激烈;及為降低生產成本及減輕中美貿易糾紛的影響,部分客户將彼等的生產基地轉移至東南亞。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.